Delivery Order SPE2DB22D9353-SPE2DB24FX1TZ
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $11,865.20, is for the delivery of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,966.25 to DMS Pharmaceutical Group Inc. for M-M-R II vaccine vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by September 12, 2025, and represents a routine procurement of immunization products for military and federal healthcare facilities....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $4,152.75 and covers the delivery of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of M-M-R II vaccine vials. This $19.8K firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 7, 2025, and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation based on its...
- This federal contract award is a delivery order worth $2,373.04 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of M-M-R II vaccine vials to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with a completion date of February 28, 2025. DMS Pharmaceutical Group Inc. also holds a...
- The Defense Logistics Agency awarded a $37,400.93 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for M-M-R II vaccine vials. The delivery order, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, carries no set-aside designation, indicating the company won the award through unrestricted federal procurement competition. This delivery order is issued under DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,133.72 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a performance period through August 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,203.30 contract is for the delivery of M-M-R II vaccine vials, with a completion date of August 7, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,186.52, is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials. The award is not associated with a set-aside designation. It represents one of several federal contract awards received by DMS Pharmaceutical Group, which holds a significant...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,299.10 for M-M-R II vaccine vials. The contract, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, was funded by the Medical Supply Chain division of the Defense Logistics Agency. This delivery order was awarded without a set-aside designation, leveraging the company's competitive...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB24FX1TZDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $11,337 contract is for the delivery of M-M-R II vaccine vials, with a completion date of March 5, 2024. The contract is issued under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025. This single-award vehicle allows the DLA to issue delivery orders for a broad range of pharmaceutical products to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group also holds separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense sites. There is no set-aside designation for this specific delivery order. As a woman-owned small business, DMS Pharmaceutical Group's status has enabled it to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 3/4/24 |